MedTrace Logo

Holistic Needs Assessment in Outpatient Cancer Care

NCT02274701 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2014-10-27

No results posted yet for this study

Summary

This study evaluates the impact of holistic needs assessment (HNA) on patient/clinician communication in outpatient cancer care. Half of the participants will complete a HNA prior to their clinical consultation. They will then take it into the consultation and it will inform a discussion around any identified areas of need. Half of the participants will be in the control group meaning there will be no additional intervention they will receive care as normal. The consultations will be audio-recorded. The patient will complete two outcome measures following the consultation.

Conditions

  • Oncology [See Also, Affected System]

Interventions

OTHER

Holistic Needs Assessment

An assessment completed by the patient in cancer care. It is recommended that this assessment is completed at key points in the care pathway, such as at diagnosis, post treatment and beginning of end of life care. The aim of this assessment is to allow the patient to discuss their most important needs as identified by them. The clinician will take any appropriate action. This may range from listening to the patient to referring to another member of the multi-disciplinary team.

Sponsors & Collaborators

  • Macmillan Cancer Support

    collaborator OTHER

  • University of the West of Scotland

    lead OTHER

Principal Investigators

  • Austyn Snowden, PhD · University of the West of Scotland

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-10-31
Completion
2016-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02274701 on ClinicalTrials.gov